These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 24284100

  • 1. Conjunction of glutathione level, NAD(P)H/FAD redox status and hypericin content as a potential factor affecting colon cancer cell resistance to photodynamic therapy with hypericin.
    Mikešová L, Mikeš J, Kovaľ J, Gyurászová K, Culka L, Vargová J, Valeková B, Fedoročko P.
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):470-83. PubMed ID: 24284100
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of hypericin-mediated photodynamic therapy cytotoxicity by MK-886: focus on ABC transporters, GDF-15 and redox status.
    Kuchárová B, Mikeš J, Jendželovský R, Vargová J, Mikešová L, Jendželovská Z, Kovaľ J, Fedoročko P.
    Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):490-503. PubMed ID: 26003114
    [Abstract] [Full Text] [Related]

  • 3. Lower sensitivity of FHC fetal colon epithelial cells to photodynamic therapy compared to HT-29 colon adenocarcinoma cells despite higher intracellular accumulation of hypericin.
    Mikeš J, Hýžďalová M, Kočí L, Jendželovský R, Kovaľ J, Vaculová A, Hofmanová J, Kozubík A, Fedoročko P.
    Photochem Photobiol Sci; 2011 Apr; 10(4):626-32. PubMed ID: 21298151
    [Abstract] [Full Text] [Related]

  • 4. The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells.
    Šemeláková M, Mikeš J, Jendželovský R, Fedoročko P.
    J Photochem Photobiol B; 2012 Dec 05; 117():115-25. PubMed ID: 23099482
    [Abstract] [Full Text] [Related]

  • 5. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells.
    Wang X, Guo Y, Yang S, Wang C, Fu X, Wang J, Mao Y, Zhang J, Li Y.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):847-53. PubMed ID: 20551295
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin.
    Kleban J, Mikes J, Horváth V, Sacková V, Hofmanová J, Kozubík A, Fedorocko P.
    J Photochem Photobiol B; 2008 Nov 13; 93(2):108-18. PubMed ID: 18771933
    [Abstract] [Full Text] [Related]

  • 7. Modulation of hypericin photodynamic therapy by pretreatment with 12 various inhibitors of arachidonic acid metabolism in colon adenocarcinoma HT-29 cells.
    Kleban J, Mikes J, Szilárdiová B, Koval J, Sacková V, Solár P, Horváth V, Hofmanová J, Kozubík A, Fedorocko P.
    Photochem Photobiol; 2007 Nov 13; 83(5):1174-85. PubMed ID: 17880512
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of oxaliplatin sensitivity in human colorectal cancer by hypericin mediated photodynamic therapy via ROS-related mechanism.
    Lin S, Lei K, Du W, Yang L, Shi H, Gao Y, Yin P, Liang X, Liu J.
    Int J Biochem Cell Biol; 2016 Feb 13; 71():24-34. PubMed ID: 26673998
    [Abstract] [Full Text] [Related]

  • 9. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
    Ali SM, Olivo M.
    Int J Oncol; 2002 Sep 13; 21(3):531-40. PubMed ID: 12168096
    [Abstract] [Full Text] [Related]

  • 10. Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.
    Jendzelovský R, Mikes J, Koval' J, Soucek K, Procházková J, Kello M, Sacková V, Hofmanová J, Kozubík A, Fedorocko P.
    Photochem Photobiol Sci; 2009 Dec 13; 8(12):1716-23. PubMed ID: 20024169
    [Abstract] [Full Text] [Related]

  • 11. The role of p53 in the efficiency of photodynamic therapy with hypericin and subsequent long-term survival of colon cancer cells.
    Mikes J, Koval' J, Jendzelovský R, Sacková V, Uhrinová I, Kello M, Kuliková L, Fedorocko P.
    Photochem Photobiol Sci; 2009 Nov 13; 8(11):1558-67. PubMed ID: 19862414
    [Abstract] [Full Text] [Related]

  • 12. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R, Gan YY, Yee KK, Soo KC, Olivo M.
    Int J Mol Med; 2007 Oct 13; 20(4):421-8. PubMed ID: 17786271
    [Abstract] [Full Text] [Related]

  • 13. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY, Bay BH, Olivo M.
    Int J Oncol; 2003 May 13; 22(5):1019-24. PubMed ID: 12684667
    [Abstract] [Full Text] [Related]

  • 14. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
    Kamuhabwa AA, Huygens A, De Witte PA.
    Int J Oncol; 2003 Nov 13; 23(5):1445-50. PubMed ID: 14532989
    [Abstract] [Full Text] [Related]

  • 15. p53 Status does not affect photodynamic cell killing induced by hypericin.
    Lee HB, Ho AS, Teo SH.
    Cancer Chemother Pharmacol; 2006 Jul 13; 58(1):91-8. PubMed ID: 16211395
    [Abstract] [Full Text] [Related]

  • 16. Photoactivation of hypericin down-regulates glutathione S-transferase activity in nasopharyngeal cancer cells.
    Du HY, Olivo M, Tan BK, Bay BH.
    Cancer Lett; 2004 Apr 30; 207(2):175-81. PubMed ID: 15072826
    [Abstract] [Full Text] [Related]

  • 17. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma.
    Sanovic R, Verwanger T, Hartl A, Krammer B.
    Photodiagnosis Photodyn Ther; 2011 Dec 30; 8(4):291-6. PubMed ID: 22122915
    [Abstract] [Full Text] [Related]

  • 18. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
    Chen B, Zupkó I, de Witte PA.
    Int J Oncol; 2001 Apr 30; 18(4):737-42. PubMed ID: 11251168
    [Abstract] [Full Text] [Related]

  • 19. YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.
    Gyurászová K, Mikeš J, Halaburková A, Jendželovský R, Fedoročko P.
    Photochem Photobiol Sci; 2016 Jun 08; 15(6):812-21. PubMed ID: 27241169
    [Abstract] [Full Text] [Related]

  • 20. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
    Buytaert E, Matroule JY, Durinck S, Close P, Kocanova S, Vandenheede JR, de Witte PA, Piette J, Agostinis P.
    Oncogene; 2008 Mar 20; 27(13):1916-29. PubMed ID: 17952126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.